In- Vivo Comparison of Anticonvulsant Effects of Gabapentin and Verapamil alone and in Combination with Diazepam on Acute Seizure Model
Keywords:
Antiepileptic drugs, Diazepam, Gabapentin, Verapamil, Status epilepticusAbstract
Objective: To compare in-vivo anticonvulsant effects of gabapentin and verapamil alone and in combination with diazepam
in acute seizure model of mice.
Methodology: This experimental study was conducted in H.E.J. Research Institute of Chemistry, International Center for
Chemical and Biological Sciences, Karachi University, from May 2009 to July 2011.
Pentylenetetrazol (PTZ) was used in the dose of 90 mg/kg subcutaneously to induce acute seizures in mice. The test drugs Gabapentin
(GBP) and Verapamil (VP) were administered by intraperitoneal route in six doses individually as well as in combination.
The reference drug Diazepam (DZ), and test drugs were administered 40 minutes before PTZ intraperitoneally. R & F was the time calculated from beginning of seizure phase to rearing
and falling of mice. HLTE was the time recorded from rearing and falling to development of generalized tonic clonic phase of
seizure. The cut off time was 40 minutes.
Results: As individual treatment regimens the anti-seizure scores and mortality protection of GB: PTZ as well as VP: PTZ were
significantly inferior to DZ in all seizure patterns, however, combination regimen of GBP:VP:PTZ in the last two higher doses
exhibited highly significant antiseizure effects with 100% mortality protection which were equivalent to reference drug DZ.
Conclusion: The Combination regimen was novel and at higher doses exhibited potent acute anti-seizure activities equal in
efficacy to DZ
References
Borowicz KK, Swiader M, Luszczki J, Czuczwar SJ. Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis. Epilepsia. 2002 Sep 1;43(9): 956-63
Mandhane SN, Aavula K, Rajamannar T. Timed pen- tylenetetrazol infusion test: a comparative analysis with sc PTZ and MES models of anticonvulsant screening in mice. Seizure. 2007 Oct 31;16(7):636-44
Treiman DM, Walker MC. Treatment of seizure emerge- ncies: convulsive and non-convulsive status epilepticus Epilepsy research. 2006 Jan 31;68:77-82
Knake S, Hamer HM, Rosenow F. Status epilepticus: a critical review. Epilepsy & Behavior. 2009 May 31;15 (1):10-4
Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser, T et al. Guidelines for the evaluation and anagement of status epilepticus. Neurocritical care. 2012 Aug 1;17(1):3-23
Chen JW, Wasterlain CG. Status epilepticus: pathophy- siology and management in adults. The Lancet Neurology 2006 Mar 31;5(3):246-56
DeLorenzo RJ. Epidemiology and clinical presentation of status epilepticus. Advances in neurology. 2005 Dec; 97:199-215
Johannessen I, Johannessen S, Landmark C. Antiepileptic drug interactions-principles and clinical implications Current neuropharmacology. 2010 Sep 1;8(3):254-67.
Asconapé JJ. Some common issues in the use of antie- pileptic drugs. InSeminars in neurology 2002; 22(01): 027-040
Delahoy P, Thompson S, Marschner IC. Pregabalin versus gabapentin in partial epilepsy: a meta-analysis of dose-response relationships. BMC neurology. 2010 Nov 1;10(1):1
LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review. JAMA. 2004;291(5):605-14
Nicita F, Spalice A, Papetti L, Nikanorova M, Iannetti P, Parisi P. Efficacy of verapamil as an adjunctive treat- ment in children with drug-resistant epilepsy: a pilot study. Seizure. 2014 Jan 31;23(1):36-40
Iannetti P, Parisi P, Spalice A, Ruggieri M, Zara F. Add- ition of verapamil in the treatment of severe myoclonic epilepsy in infancy. Epilepsy research. 2009 Jul 31;85 (1):89-95
Grone BP, Baraban SC. Animal models in epilepsy re- search: legacies and new directions. Nature neuroscience 2015 Mar 1;18(3):339-43
Kandratavicius L, Balista PA, Lopes-Aguiar C, Ruggiero RN, Umeoka EH, Garcia-Cairasco N, et al. Animal models of epilepsy: use and limitations. Neuropsychiatric Disease and Treatment. 2014;10:1693-1705
Porter RJ, Cereghino JJ, Gladding GD, Hessie BJ, Kupferberg HJ, Scoville B et al. Antiepileptic drug development program. Cleveland Clinic Quarterly. 1984; 51(2):293-305
Raj D, Gulati S, Lodha R. Status epilep. Indian J Pediatr. 2011; 78(2): 219-226
Raines A, Henderson TR, Swinyard EA, Dretchen KL. Comparison of midazolam and diazepam by the intramu- scular route for the control of seizures in a mouse model of status epilepticus. Epilepsia. 1990 Jun 1;31(3):313-7
Reddy DS, Kuruba R. Experimental models of status epilepticus and neuronal injury for evaluation of therap- eutic interventions. International journal of molecular sciences. 2013 Sep 5;14(9):18284-318
Rubio C, Rubio-Osornio M, Retana-Márquez S, López M, Custodio V, Paz C. In vivo experimental models of epilepsy. Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry- Central Nervous System Agents). 2010 Dec 1;10(4):298- 309
Stafstrom CE. Mechanisms of action of antiepileptic drugs: the search for synergy. CurrOpin Neurol. 2010; 23:157-163
Schmitt FC, Dehnicke C, Merschhemke M, Meencke HJ. Verapamil attenuates the malignant treatment course in recurrent status epilepticus. Epilepsy & Behavior. 2010 Apr 30;17(4):565-8
Sutton KG, Martin DJ, Pinnock RD, Lee K, Scott RH. Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. British journal of pharmacology. 2002 Jan 1;135(1):257- 65
Giordanetto F, Knerr L, Wållberg A. T-type calcium channels inhibitors: a patent review. Expert opinion on therapeutic patents. 2011 Jan 1;21(1):85-101
Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy & behavior 2005 Sep 30;7:1-64
Keränen T, Holopainen I. [Mechanisms of action and clinical use of antiepileptic drugs]. Duodecim; laaketietee- llinenaikakauskirja. 2008 Dec;125(22):2533
Sills GJ. The mechanisms of action of gabapentin and pregabalin. Current opinion in pharmacology. 2006 Feb 28;6(1):108-13
Summers MA, Moore JL, McAuley JW. Use of verap- amil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy. Annals of Pharmacotherapy. 2004 Oct 1;38(10):1631-4
Iftinca MC, Zamponi GW. Regulation of neuronal T-type calcium channels. Trends in pharmacological sciences 2009 Jan 31;30(1):32-40
Khosravani H, Zamponi GW. Voltage-gated calcium chan- nels and idiopathic generalized epilepsies. Physiological reviews. 2006 Jul 1;86(3):941-66
Bian, F, Li Z, Offord J, Davis MD, McCormick J, Taylor CP, Walker LC. Calcium channel alpha 2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo auto-radiographic study in alpha 2-delta type 1 genetically modified mice. Brain Res. 2006; 1075:68- 80
Zamponi GW, Lory P, Perez-Reyes E. Role of voltage-
-gated calcium channels in epilepsy. PflügersArchiv- European Journal of Physiology. 2010 Jul 1;460(2):39 5-403
Kaminski RM, Mazurek M, Turski WA, Kleinrok Z, Czuczwar SJ. Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures. Pharmacology Biochemistry and Behavior. 2001 Apr 30;68(4):661-8
Triggle DJ. L-type calcium channels. Current pharmaceu- tical design. 2006 Feb 1;12(4):443-57
Kaminski RM, Mazurek M, Turski WA, Kleinrok Z, Czuczwar SJ. Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures. Pharmacology Biochemistry and Behavior. 2001 Apr 30;68(4):661-8
Kuak W, Sobaniec W, Wojtal K, Czuczwar SJ. Calcium modulation in epilepsy. Pol J Pharmacol. 2004;56:29-41.
Belgium, 25-28 August 2007. Canadian journal of physiology and pharmacology. 2008 Feb 22;86(3):113- 21
Khanna N, Bhalla S, Verma V, Sharma KK. Modulatory effects of nifedipine and nimodipine in experimental convulsions. Indian Journal of pharmacology. 2000 Nov 1;32(6):347-52
Iannetti P, Spalice A, Parisi P. Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia. 2005 Jun 1;46(6):967-9
Falco FA, Bartiromo U, Majello L, Geronimo, G, Mundo P. Calcium antagonist nimodipine in intractable epilepsy. Epilepsia. 1992; 33(2): 343-345
Meyer FB, Anderson RE, Sundt TM. Anticonvulsant effects of dihyvdropyridine Ca2+ antagonists in electro- cortical shock seizures. Epilepsia. 1990; 31:68-74
Brandt, Saveland H,Ljunggre B, Andersson KE. Control of epilepsy partialiscontinuans with intravenous nimodipine: report of two cases. J Neurol. 1988; 69:949- 50
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Itefaq Hussain Qureshi, Shahbana Usman Simjee
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
